印度：新专利法可能会限制获得艾滋病毒/艾滋病治疗的机会。
India: New patent law may restrict access to HIV/AIDS treatments.
作者信息
Cruess Gord
出版信息
HIV AIDS Policy Law Rev. 2005 Aug;10(2):28-30.
PMID:16365971
Abstract
On 4 April 2005, India's Patents (Amendment) Act, 2005 (the Act) received presidential assent. The Act, which represents a major shift in Indian patent policy, raises serious concerns that the supply of generic drugs to developing countries could decline.
摘要
2005年4月4日，印度《2005年专利（修正案）法案》（以下简称“该法案”）获得总统批准。该法案代表了印度专利政策的重大转变，引发了人们对发展中国家仿制药供应可能减少的严重担忧。
Zotero 插件